Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
3,300
Funds Holding Change
+278
Funds Holding Growth
+9%
Value
$1.04T
Holding in Top 10
1,215
Top 10 Change
-10
Top 10 Growth
-0.8%
Value Growth
-1%
New
364
Increased
1,229
Reduced
1,538
Closed
52
Capital Inflow
$39.1B
Capital Outflow
$27.6B
Net Capital Flow
+$11.4B
Capital Flow Change
-$625M
Calls
$11.6B
Puts
$15B
Net Calls
-$3.49B
Put/Call Ratio
1.3